Pregnancy

Double-blind controlled trial of progesterone substitution in threatened abortion

Gerhard I et al., 1987

Detection of preterm labor by ambulatory monitoring of uterine activity for the management of oral tocolysis

Katz M et al., 1986

The risk of fetal anomalies as a result of progesterone therapy during pregnancy

Check JH et al., 1986

The effects of oral administration of progesterone for premature labor

Erny R et al., 1986

Embryotoxicity of a single dose of medroxyprogesterone acetate (MPA) and maternal serum MPA concentrations in cynomolgus monkey (Macaca fascicularis)

Prahalada S et al., 1985

The association of subclinical infection with preterm labor: the role of C-reactive protein

Potkul RK et al., 1985

Fetal malformations following progesterone therapy during pregnancy: a preliminary report

Rock JA et al., 1985

Teratogenicity of progestogens given during the first trimester of pregnancy

Katz Z et al., 1985

Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974

Resseguie LJ et al., 1985

Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate

Yemini M et al., 1985

Medroxyprogesterone acetate does not perturb the profile of steroid metabolites in urine during pregnancy

Yovich JL et al., 1985

The effect of medroxyprogesterone acetate (Depo-Provera) on prenatal development in the baboon (Papio anubis): a preliminary study

Tarara R, 1984

Causes of preterm delivery

Gravett MG, 1984

Silent chorioamnionitis as a cause of preterm labor refractory to tocolytic therapy

Hameed C et al., 1984

Correlation of maternal serum C-reactive protein with outcome of tocolysis

Handwerker SM et al., 1984

Oral administration of micronized natural progesterone in late human pregnancy. Effects on progesterone and estrogen concentrations in the plasma, placenta, and myometrium

Ferre F et al., 1984

Evaluation of the teratogenic potential of delalutin (17 alpha-hydroxyprogesterone caproate) in mice

Seegmiller RE et al., 1983

Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations

Michaelis J et al., 1983

Teratogenic effects of cyproterone acetate and medroxyprogesterone treatment during the pre- and postimplantation period of mouse embryos. I

Eibs HG et al., 1982

The outcome of pregnancy resulting from clomiphene-induced ovulation

Correy JF et al., 1982

Evaluation of the use of Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy

Varma TR et al., 1982

Endocrine, structural, and functional changes in the uterus during premature labor

Garfield RE et al., 1982

An epidemiologic study of preterm delivery

Berkowitz GS, 1981

Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: a comparison with ritodrine

Kauppila A et al., 1980

Intelligence and prenatal progesterone

Meyer-Bahlburg HF, 1979

High-risk prematurity--progestin treatment and steroid studies

Johnson JW et al., 1979

Gestational outcome of clomiphene-related conceptions

Adashi EY et al., 1979

Maternal progestins as a possible cause of hypospadias

Aarskog D, 1979

Serum progesterone and estradiol in pregnant women selected for progestagen treatment

Dubin NH et al., 1979

Prenatal progesterone. I. Its effect on development and on intellectual and academic achievement

Lynch A et al., 1978

Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence

Csapo AI et al., 1978

Prenatal toxicity of medroxyprogesterone acetate in rabbits, rats, and mice

Andrew FD et al., 1977

Suboptimal pregnancy outcome among women with prior abortions and premature births

Funderburk SJ et al., 1976

Hormone May Curb Premature Births

Associated Press Omaha World Herald, 1975

Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor

Johnson JW et al., 1975

Outcome of pregnancy after induced ovulation. Follow-up of pregnancies and children born after clomiphene therapy

Hack M et al., 1972

Hormonal therapy for control of the incompetent os of pregnancy

Sherman AI, 1966

THE EFFECT OF PROVERA ON THE FETUS

Burstein R et al., 1964

DOUBLE-BLIND TRIAL OF A PROGESTIN IN HABITUAL ABORTION

Goldzieher JW, 1964

Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate

Shearman RP et al., 1963

The place of progesterone in the treatment of abortion

Morgan J et al., 1960

Masculinization of the female fetus associated with administration of oral and intramuscular progestins during gestation: non-adrenal female pseudohermaphrodism

Wilkins L et al., 1958

Progesterone implantation in habitual abortion

Swyer GI et al., 1953

Habitual abortion; prophylactic value of progesterone pellet implantation

Bishop PM et al., 1950

Recurrent pregnancy loss: a committee opinion

Practice Committee of the American Society for Reproductive Medicine, 2026

Alpha-Lipoic Acid and Leucine as Adjunct Therapy for Persistent First-Trimester Subchorionic Hematomas in Assisted Reproductive Technology Pregnancies

Bano T et al., 2026

Neonatal characteristics of children conceived with in vitro fertilization or intrauterine insemination compared with sibling births from unassisted conceptions

Reeder MR et al., 2026

Association between endometriosis and pregnancy complications: A nationwide retrospective analysis (2000-2021)

Hsu JZ et al., 2025

A systematic review on the role of paternal factors in human placental development, function, and pregnancy-related disorders

Johnson J et al., 2025

O-305 Predictive performance of the Fetal-Medicine-Foundation first-trimester screening for preeclampsia in pregnancies following ART with fresh embryo transfer, frozen embryo transfer and oocyte donation

Kjaer ASL et al., 2025

O-014 Unraveling the interplay of gut microbiota, metabolic alterations, and endometrial senescence in polycystic ovary syndrome and its implications for adverse pregnancy outcomes

Jing M et al., 2025

O-306 What are the clinical implications of large-for-gestational age (LGA) babies conceived after a frozen-thawed embryo transfer (FET)?: a population-based cohort study

Venetis C et al., 2025

Antiphospholipid syndrome in pregnancy: a comprehensive literature review

Murvai VR et al., 2025

Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure

Garmendia JV et al., 2025

Association of in vitro fertilization with severe maternal morbidity in low-risk patients without comorbidities

Solmonovich R et al., 2025

Risk of placenta previa in assisted reproductive technology: A Nordic population study with sibling analyses

Landsverk E et al., 2025

A nomogram and risk stratification to predict subsequent pregnancy loss in patients with recurrent pregnancy loss

Li M et al., 2024

Hydroxychloroquine in recurrent pregnancy loss: data from a French prospective multicenter registry

Dernoncourt A et al., 2024

Prenatal Cannabis Use and Maternal Pregnancy Outcomes

Young-Wolff KC et al., 2024

Vaginal micronised progesterone for the prevention of hypertensive disorders of pregnancy: A systematic review and meta-analysis

Melo P et al., 2024